Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594
Keywords: Cancer; JX-594; Oncolytic poxvirus; Oncolytic viruses; granulocytemacrophage colony stimulating factor (GM-CSF); metastatic disease; multiple mechanisms-of-action (MOAs); vaccinia vaccine strain
Document Type: Research Article
Publication date: 2012-07-01
- Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.